IR Event

news

June 11
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Continue Reading
June 11
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
Continue Reading
May 11
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
Continue Reading
April 29
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
Continue Reading
April 27
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Continue Reading